Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis

被引:256
作者
Hollingshead, M [1 ]
Burke, CT [1 ]
Mauro, MA [1 ]
Weeks, SM [1 ]
Dixon, RG [1 ]
Jaques, PF [1 ]
机构
[1] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1097/01.RVI.0000156265.79960.86
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: The purpose of this study was to evaluate the utility of transcatheter thrombolytic therapy in 20 patients with acute or subacute (symptoms < 40 days) portal and/or mesenteric vein thrombosis with severe symptoms, deteriorating clinical condition, and/or persistent symptoms despite anticoagulation. MATERIALS AND METHODS: This retrospective study examined 12 male patients and eight female patients seen over a period of 11 years. The average age was 37.6 years. Four of the patients had previously undergone liver transplantation. An anatomic classification system was established to describe the extent of thrombus at the time of diagnosis. Patients were treated with thrombolytic therapy via the transhepatic route, common femoral vein route, and/or superior mesenteric artery route. Improvement in symptoms, avoidance of bowel resection, complications, and radiographic evidence of clot resolution were the main clinical outcomes. RESULTS: Fifteen of the 20 patients exhibited some degree of lysis of the thrombus. Three patients had complete resolution, 12 had partial resolution, and five had no resolution. Eighty-five percent of patients (n = 17) had resolution of symptoms. Sixty percent of patients (n = 12) developed a major complication. No patients required bowel resection after thrombolytic therapy. One patient died with gastrointestinal hemorrhage and septic shock 2 weeks after thrombolytic therapy. Other major complications included bleeding and conditions requiring transfusion. No patients developed new portal or mesenteric thromboses. Two of the patients who received transplants eventually required repeat transplantation. CONCLUSIONS: Transcatheter thrombolysis was beneficial in avoiding patient death, resolving thrombus, improving symptoms, and avoiding bowel resection. However, there was a high complication rate, indicating that this therapy should be reserved for patients with severe disease. Further evaluation of these techniques and outcomes should continue to be pursued.
引用
收藏
页码:651 / 661
页数:11
相关论文
共 31 条
[1]  
Alam H, 1997, AM SURGEON, V63, P681
[2]  
BILBAO JI, 1995, CARDIOVASC INTER RAD, V18, P323
[3]   NONCAVERNOMATOUS PORTAL-VEIN THROMBOSIS IN HEPATIC CIRRHOSIS - TREATMENT WITH TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AND LOCAL THROMBOLYSIS [J].
BLUM, U ;
HAAG, K ;
ROSSLE, M ;
OCHS, A ;
GABELMANN, A ;
BOOS, S ;
LANGER, M .
RADIOLOGY, 1995, 195 (01) :153-157
[4]   Acute mesenteric venous thrombosis: Case for nonoperative management [J].
Brunaud, L ;
Antunes, L ;
Collinet-Adler, S ;
Marchal, F ;
Ayav, A ;
Bresler, L ;
Boissel, P .
JOURNAL OF VASCULAR SURGERY, 2001, 34 (04) :673-679
[5]   PORTAL-VEIN THROMBOSIS - A REVIEW [J].
COHEN, J ;
EDELMAN, RR ;
CHOPRA, S .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 (02) :173-182
[6]   Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy [J].
Condat, B ;
Pessione, F ;
Denninger, MH ;
Hillaire, S ;
Valla, D .
HEPATOLOGY, 2000, 32 (03) :466-470
[7]   Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy [J].
Condat, B ;
Pessione, F ;
Hillaire, S ;
Denninger, MH ;
Guillin, MC ;
Poliquin, M ;
Hadengue, A ;
Erlinger, S ;
Valla, D .
GASTROENTEROLOGY, 2001, 120 (02) :490-497
[8]  
Janssen HLA, 2000, SCAND J GASTROENTERO, V35, P69
[9]   Current concepts - Mesenteric venous thrombosis [J].
Kumar, S ;
Sarr, MG ;
Kamath, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1683-1688
[10]   Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis [J].
Lopera, JE ;
Correa, G ;
Brazzini, A ;
Ustunsoz, B ;
Patel, S ;
Janchai, A ;
Castaneda-Zuniga, W .
JOURNAL OF VASCULAR SURGERY, 2002, 36 (05) :1058-1061